Blog

Clinical Trial Disruption Due to COVID-19: How Bioclinica Is Responding

The Expanded Role of RTSM to Meet the Needs of Novel Clinical Trial Designs – Part II

Drop the Burden of CTMS Implementation

Novel Clinical Trial Designs and Their Impact on the Role of RTSM – Part I

The Cost of Change: Clinical Research is Taking Longer than Ever to Execute

The Cost of Change: How Increasing Clinical Trial Complexity is Driving Added Expense

Increasing Awareness of NAFLD/NASH – 2019 Is “the Year of NASH” According to Goldman Sachs

Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials – Where Do We Stand?

Electronic Data Capture (EDC) Provider Selection – Finding the Best Fit for You